Animal Biotechnology and Stem Cell Therapy
Animal Biotechnology delivers fresh tools for refining human health and animal health and welfare and increasing livestock productivity. It improves the food we eat - meat, milk and eggs. Biotechnology can improve an animal impact on the environment and It enhances ability to detect, treat and prevent diseases. Stem-cell therapy is new techniques that become argumentative developments such as the ability to isolate and culture embryonic stem cells it leads to create stem cells using somatic cell nuclear transfer and their use of techniques to create induced pluripotent stem cells.
- Stem cell therapy and transplantation
- Transgenic animals: Current scenario and case study
- Livestock development and poultry
- Strategies for conservation of indigenous livestock
- Animal bioreactor for vaccine and enzyme production
- Stem Cell culture methodologies and media design
- Maintenance and manipulation of stem cell
Related Conference of Animal Biotechnology and Stem Cell Therapy
November 16-17, 2026
19th International Conference on Human Genomics and Genomic Medicine
Tokyo, Japan
February 18-19, 2027
22nd World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Singapore City, Singapore
March 11-12, 2027
17th International Conference on Human Genetics and Genetic Diseases
Berlin, Germany
Animal Biotechnology and Stem Cell Therapy Conference Speakers
Recommended Sessions
- Agricultural Biotechnology
- Animal Biotechnology and Stem Cell Therapy
- Aquaculture and Marine Biotechnology
- Biochemistry and Pharmaceutical Technology
- Bioenergy and Biofuels
- Bioethics and Biosafety
- Bioinformatics and Systems Synthetic Biology
- Biomaterials and Tissue Engineering
- Biomedical and Metabolic Engineering
- Biontrepreneurship and Global Bio Economy
- Biophysics
- Bioprocess and Bio refinery
- Biosensors
- Cancer Biology and Immunology
- Cell Biology and Microbiology
- Chemical Engineering and Biomechanics
- Current Scenario of Biotechnology
- Environmental and Petroleum biotechnology
- Food Process and Nutrition Biotechnology
- Forensic Science
- Genetics and Recombinat DNA Technology
- Molecular Biology
- Molecular Modelling and Biopolymers
- Nano Biotechnology and Vaccine Technology
- Plant Biotechnology and Tissue culture
- Protein and Enzyme Engineering
- Proteomics and Genomics
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Advanced Imaging and Single-Cell Technologies - cellscience-cs-2027 (UK)
- Animal Genetics - Genome 2027 (Germany)
- Artificial Intelligence in Cell and Molecular Research - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - Genome 2027 (Germany)
- Biomarkers and Microarrays - Genome 2027 (Germany)
- Biotechnology and Molecular Therapeutics - cellscience-cs-2027 (UK)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Cell Biology and Molecular Oncology - cellscience-cs-2027 (UK)
- Cancer Genomics - Genome 2027 (Germany)
- Cell Biology and Cellular Mechanisms - cellscience-cs-2027 (UK)
- Cellular Metabolism and Metabolic Biology - cellscience-cs-2027 (UK)
- Cellular signaling and Signal Transduction - cellscience-cs-2027 (UK)
- Clinical genomics - Genome 2027 (Germany)
- Comparative Genomics - Genome 2027 (Germany)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Emerging Technologies and Future Directions in Cell Science - cellscience-cs-2027 (UK)
- Epigenomics and Epigenetics - Genome 2027 (Germany)
- Functional Genomics - Genome 2027 (Germany)
- Gene Editing and Genetic Engineering - Genome 2027 (Germany)
- Genetic Disorder - Genome 2027 (Germany)
- Genetics, Genomics and Genome Biology - cellscience-cs-2027 (UK)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Genomic Instability - Genome 2027 (Germany)
- Genomic Medicine - Genome 2027 (Germany)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Immunology and Cellular Immunity - cellscience-cs-2027 (UK)
- Microbial Genomics - Genome 2027 (Germany)
- Molecular Biology and Gene Regulation - cellscience-cs-2027 (UK)
- Molecular Diagnostics and Biomarkers - cellscience-cs-2027 (UK)
- Molecular Medicine and Translational Research - cellscience-cs-2027 (UK)
- Molecular Microbiology and Host–Pathogen Interactions - cellscience-cs-2027 (UK)
- Next generation sequencing - Genome 2027 (Germany)
- Nutrigenomics - Genome 2027 (Germany)
- Personalized and Regenerative Medicine - Genome 2027 (Germany)
- Pharmacogenomics - Genome 2027 (Germany)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Plant Genomics and Molecular Pharming - Genome 2027 (Germany)
- Stem Cell Biology and Regenerative Medicine - cellscience-cs-2027 (UK)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Structural Genomics - Genome 2027 (Germany)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)
- Trends in Genomics and Pharmacogenomics - Genome 2027 (Germany)